The FDA has approved the first systemic therapy for patients with NSCLC or pancreatic adenocarcinoma with an NRG1 gene fusion.

I’ve learned to live in the present by avoiding clocks, a necessary change in my life after having breast cancer.

Partial nephrectomy showed similar overall and cancer-specific survival rates to radiofrequency ablation in patients with ...

Patients with locally advanced pancreatic cancer demonstrated a two-month difference in survival with tumor-treating fields ...

The FDA has granted Breakthrough Therapy designation to sacituzumab tirumotecan for patients with advanced or metastatic ...

In patients with advanced solid tumors, treatment with nemvaleukin with or without Keytruda demonstrated antitumor activity ...

When my grandmother passed away one Thanksgiving after my colon cancer diagnosis, I realized how grateful I am for her life ...

Singer-songwriter Danielia Cotton, a thyroid cancer survivor and marathon runner shared how her experiences impact her art.

The FDA has accepted a biologics license application for Blenrep plus bortezomib or pomalidomide for patients with relapsed ...

The primary endpoint of overall survival was missed in the SKYSCRAPER-01 study assessing tiragolumab plus Tecentriq in some ...

Current treatments for patients with relapsed or refractory chronic lymphocytic leukemia have shown better outcomes than ...

In patients with low-grade prostate cancer, adhering to the recommended dietary guidelines may slow the risk of prostate ...